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Abstract
Background:  Sarcoidosis  is  a  multisystemic  disorder  of  unknown  etiology.  Its  diagnosis  is  based
on compatible  clinical  and  radiological  features  and  supported  by  histological  demonstration  of
epithelioid  cell  noncaseating  granulomas  with  exclusion  of  other  causes.  Endobronchial  ultra-
sound combined  with  transbronchial  needle  aspiration  (EBUS-TBNA)  has  been  proposed  as  a
valuable tool  in  obtaining  suitable  tissue  sample.
The aim  of  this  study  was  to  evaluate  the  contribution  of  EBUS-TBNA  to  the  diagnosis  of  stages
I and  II  thoracic  sarcoidosis  in  a  community-based  hospital.
Methods:  A  prospective  study  was  conducted  in  patients  with  suspected  stages  I  and  II  pul-
monary sarcoidosis,  based  on  clinical  and  radiological  data,  who  were  being  followed  in  our
Interstitial Lung  Disorders  Outpatient  Clinic  or  sent  from  other  hospitals  to  our  Respiratory
Endoscopy  Unit  for  diagnostic  procedures.  All  suitable  and  ﬁt  patients  underwent  EBUS-TBNA
between March  2010  and  June  2013.
We  assessed  demographic  characteristics,  radiological  stages,  cytological/histological  exam-
ination and  diagnostic  techniques  performed.
Results:  In  the  period  considered  39  patients  underwent  EBUS-TBNA  for  suspected  stages  I  and
II thoracic  sarcoidosis  and  adequate  samples  were  obtained  in  38  (97.4%).  Within  this  popula-
tion, 33  (84.6%)  patients  had  a  deﬁnite  diagnosis  of  sarcoidosis,  of  which  31  patients  (93.9%)
were conﬁrmed  to  have  epithelioid  noncaseating  granulomas  by  EBUS-TBNA.  Four  patients
were submitted  to  surgical  procedures  (three  to  mediastinoscopy  and  one  to  open  surgical
lung biopsy).
Data  analysis  allowed  to  calculate  a  sensitivity,  speciﬁcity,  positive  predictive  value,  negative
predictive  value  and  diagnostic  accuracy  of  93.9%,  100%,  100%,  75.0%  and  94.8%,  respectively.
No complications  were  observed.
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Conclusions:  EBUS-TBNA  is  a  valuable  tool  in  the  diagnostic  workup  of  patients  with  suspected
stages I  and  II  thoracic  sarcoidosis  providing  a  substantial  number  of  pathological  conﬁrmations
and with  few  complications.  Its  high  diagnostic  accuracy  precludes  the  need  for  more  invasive
procedures  such  as  surgical  biopsy.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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Diagnóstico  de  sarcoidose  na  era  da  Ecoendoscopia  brônquica  associada  a  Punc¸ão
Aspirativa  Transbrônquica
Resumo
Antecedentes:  A  Sarcoidose  é  uma  doenc¸a  multissistémica  de  etiologia  desconhecida.  O  seu
diagnóstico  baseia-se  em  características  clínicas  e  radiológicas  compatíveis  e  é  apoiado  pela
demonstrac¸ão histológica  de  granulomas  epitelióides  não  caseosos,  com  a  exclusão  de  outras
causas. A  ecoendoscopia  brônquica  combinada  com  a  punc¸ão  aspirativa  transbrônquica  (EBUS-
TBNA) foi  proposta  como  uma  ferramenta  valiosa  na  obtenc¸ão  de  amostras  de  tecido  adequadas.
O objectivo  deste  estudo  foi  avaliar  o  contributo  da  EBUS-TBNA  para  o  diagnóstico  de  sar-
coidose torácica  de  estádio  I  e  II  num  hospital  central.
Metodologia:  Foi  realizado  um  estudo  prospectivo  em  doentes  com  suspeita  de  sarcoidose  torá-
cica de  estádio  I  e  II,  com  base  em  dados  clínicos  e  radiológicos,  que  estavam  a  ser  seguidos
na nossa  Clínica  Ambulatória  de  Doenc¸as  Pulmonares  Intersticiais,  ou  foram  enviados  de  outros
hospitais para  a  nossa  Unidade  de  Endoscopia  Respiratória,  para  os  procedimentos  de  diagnós-
tico. Todos  os  doentes  adequados  e  aptos  foram  submetidos  a  EBUS-TBNA,  entre  Marc¸o de  2010
e Junho  de  2013.
Avaliámos  as  características  demográﬁcas,  os  estádios  radiológicos,  exames  citológi-
cos/histológicos  e  técnicas  de  diagnóstico  usados.
Resultados:  No  período  referido  anteriormente,  39  doentes  foram  submetidos  a  EBUS-TBNA
para a  suspeita  de  sarcoidose  torácica  de  estádio  I  e  II,  e  foram  obtidas  amostras  adequadas  em
38 deles  (97,4%).  Nesta  populac¸ão,  33  (84,6%)  doentes  receberam  um  diagnóstico  deﬁnitivo  de
sarcoidose,  dos  quais  31  doentes  (93,9%)  foram  conﬁrmados  como  tendo  granulomas  epitelioides
não caseosos,  pela  EBUS-TBNA.  Quatro  doentes  foram  submetidos  a  procedimentos  cirúrgicos
(três a  mediastinoscopia  e  outro  a  biopsia  pulmonar  cirúrgica  aberta).
A análise  dos  dados  permitiu  calcular  uma  sensibilidade,  especiﬁcidade,  valor  preditivo  pos-
itivo, valor  preditivo  negativo  e  acuidade  diagnóstica  de  93,9%,  100%,  100%,  75,0%  e  94,8%,
respectivamente.  Não  foram  observadas  complicac¸ões.
Conclusões:  A  EBUS-TBNA  é  uma  ferramenta  valiosa  na  abordagem  diagnóstica  dos  doentes
com suspeita  de  sarcoidose  torácica  de  estádio  I e  II,  proporcionando  um  número  importante
de conﬁrmac¸ões  patológicas  e  com  poucas  complicac¸ões.  A  sua  elevada  acuidade  diagnóstica
exclui a  necessidade  de  procedimentos  mais  invasivos  como  uma  biópsia  cirúrgica.
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arcoidosis  is  a  multisystemic  disorder  of  unknown  cause.
t  commonly  affects  young  and  middle-aged  adults  and
requently  presents  with  bilateral  hilar  lymphadenopathy,
ulmonary  inﬁltrates,  ocular  and  skin  lesions,  but  virtually
ll  organs  may  be  involved.  The  course  and  prognosis  were
ound  to  correlate  with  the  clinical  onset  and  the  extent
f  the  disease.  An  acute  onset  with  erythema  nodosum
r  asymptomatic  bilateral  hilar  lymphadenopathy  usually
eralds  a  self-limiting  course  whereas  an  insidious  onset,
specially  with  multiple  extra-pulmonary  manifestations,
ay  be  followed  by  relentless  progressive  ﬁbrosis  of  theungs  and  other  organs.1 The  heterogeneity  in  prevalence,
isease  presentation  and  severity  is  signiﬁcant  among  dif-
erent  ethnic  and  racial  groups  and  in  various  countries.  The
d
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revalence  ranges  from  less  than  one  case  to  40  cases  per
00,000.2
The  diagnosis  of  sarcoidosis  is  based  on  a compati-
le  clinical  and  radiological  picture,  histological  evidence
f  noncaseating  granulomas  and  exclusion  of  other  dis-
ases  capable  of  producing  a  similar  histological  or  clinical
icture.3,4
The  development  of  endobronchial  ultrasound  (EBUS),
hich  enables  real-time  visualization  of  mediastinal  and
ilar  structures  combined  with  transbronchial  needle  aspi-
ation  (EBUS-TBNA),  currently  allows  safe  and  effective
unctioning  of  mediastinal  and  hilar  lymph  nodes.  EBUS-
BNA  is  widely  recognized  as  being  very  useful  in  the
iagnosis  and  staging  of  lung  cancer.  However,  its  impor-
ance  in  the  diagnosis  of  benign  pathology  of  the  chest,
ncluding  sarcoidosis,  is  progressively  increasing.
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Pathological  conﬁrmation  has  been  most  commonly
achieved  by  ﬂexible  bronchoscopy  with  standard  broncho-
scopic  techniques  (transbronchial  lung  biopsy  and  bronchial
biopsy),  which  has  a  yield  of  approximately  53--70%  in
patients  with  pulmonary  sarcoidosis.5,6 EBUS-TBNA  is  gaining
momentum  as  an  important  new  technique  for  the  diagno-
sis  of  enlarged  lymph  nodes  due  to  sarcoidosis.  Recent  data
from  randomized  trials  have  demonstrated  its  superiority
to  conventional  TBNA  with  a  19-G  needle7 and  bronchial
and  transbronchial  biopsies6 for  the  diagnosis  of  pulmonary
sarcoidosis.
The  Granuloma  Trial  presented  a  diagnostic  yield  for
detection  of  granulomas  of  80%  with  EBUS-TBNA  in  patients
with  suspected  sarcoidosis.6
In  a  recent  editorial,  Culver  and  Costabel  stated  that
although  there  is  consolidated  evidence  of  the  advantages
of  EBUS-TBNA  over  other  techniques,  a  most  appropriate
way  to  study  the  usefulness  of  EBUS-TBNA  would  be  to  eval-
uate  consecutive  subjects  for  whom  sarcoidosis  is  in  the
diferential  diagnosis,  this  would  mirror  the  population  that
physicians  encounter  in  their  regular  practice.8
Materials and methods
A  prospective  study  was  conducted  in  patients  with  sus-
pected  stages  I and  II  pulmonary  sarcoidosis  based  on
clinical  and  radiological  data  followed  in  our  Interstitial
Lung  Disorders  Outpatient  Clinic  or  sent  from  other  hos-
pitals  to  our  Respiratory  Endoscopy  Unit  for  diagnostic
procedures.  All  patients  with  clinical  and  radiological
suspicion  of  stages  I and  II  pulmonary  sarcoidosis  underwent
EBUS-TBNA  for  diagnostic  purposes  in  our  hospital  between
March  2010  and  June  2013.  Exclusion  criteria  were:  obvious
organ  involvement  of  sarcoidosis  where  there  was  the  pos-
sibility  of  conﬁrming  the  diagnosis  with  a  minimally  invasive
diagnostic  procedure,  Löfgren  syndrome  and  inability  to
undergo  or  consent  to  the  procedure.
We  assessed  demographic  characteristics,  chest  radio-
graphy  stages,  nodal  stations  punctured,  cytological  and/or
histological  examination,  other  diagnostic  techniques  [bron-
choalveolar  lavage  (BAL),  bronchial  biopsy,  transbronchial
lung  biopsy  (TBLB)  or  biopsies  from  other  sites]  and  follow-
up  including  the  need  for  surgical  biopsy  (mediastinoscopy/
video-assisted  thoracic  surgery  (VATS)/thoracotomy).
Other  exams  were  performed  concurrently  according  to,
clinical  decisions  related  to  ROSE  results,  endoscopic  ﬁnd-
ings  and  technical  and  anesthetic  limitations.
BAL  was  performed  when  technically  possible  and  if  not
performed  previously  and  if  available  from  the  processing
external  laboratory.
Sarcoidosis  was  diagnosed  based  upon  a  compatible
clinical  and  radiological  picture  and  where  epithelioid  non-
caseating  granulomas  could  be  demonstrated  with  exclusion
of  other  known  causes.4
EBUS-TBNA  was  performed  under  general  anesthesia
through  a  rigid  scope  (KARL  STORZ  GmbH  &  Co.  KG,  Tut-
tlingen,  Germany)  using  a  dedicated  bronchoscope  equipped
with  a  distal  7.5-MHz  curved  linear  ultrasound  trans-
ducer  probe  (BF-UC180F,  Olympus  Ltd,  Tokyo,  Japan)  and
ultrasound  image  processor  (EU-ME1;  Olympus  Ltd,  Tokyo,
Japan).  A  22-G  cytology  needle  (MA-201SX4022,  Olympus
Ltd,  Tokyo,  Japan)  was  used  to  obtain  specimens.
(
c
qTransbronchial  Needle  Aspiration  era  239
Cytological  samples  were  prepared,  stained  (hema-
oxylin/eosin)  and  evaluated  on  site  whenever  a  pathologist
as  available  --  rapid  on  site  evaluation  (ROSE).  When
OSE  was  not  possible  a  minimum  of  4  nodal  aspirates  was
btained.
Blood  clot  cores  obtained  from  the  EBUS-TBNA  aspirates
ere  sent  in  formalin  for  histological  examination.
Samples  were  also  sent  for  mycobacteriological  tests
iven  the  intermediate  incidence  of  tuberculosis  in  Portugal.
Cytological  samples  were  considered  adequate  when  the
ample  contained  at  least  40  benign-appearing  lymphocytes
n  a  high-power  ﬁeld  in  the  areas  of  highest  cellularity  of  the
mear,  there  was  identiﬁcation  of  large  numbers  of  anthra-
otic  pigment  and  macrophages  or  large  clusters  of  admixed
ymphocytes  and  pigmented  macrophages  or  malignancy
r  granulomatous  disease  was  seen  with  small  numbers  of
ymphocytes,  as  commonly  accepted.9 Histological  samples
ere  considered  representative  when  nodal  tissue,  granulo-
as  or  other  pathological  ﬁnding  was  observed.
Follow  up  data  was  obtained  for  all  patients  including
linical  and  radiological  evolution  and  subsequent  exams
erformed.
Descriptive  statistical  measures  of  the  studied  varia-
les  included  mean  and  standard  deviation  for  continuous
ariables,  and  absolute  frequency  and  percentage  for  each
ategory  of  a  categorical  variable.  Diagnostic  sensitivity,
peciﬁcity,  positive  predictive  value,  negative  predictive
alue  and  accuracy  for  EBUS-TBNA  were  calculated.
This  study  has  been  approved  by  our  hospital’s  Ethics
ommittee.
esults
uring  the  study  period  39  patients  underwent  EBUS-TBNA
or  suspected  pulmonary  sarcoidosis  and  its  characteristics
re  described  in  Table  1.
The  majority  of  patients  were  female  (22/56.4%)  with
n  average  age  of  46.7  ±  16  years.  Suspected  radiological
tage  I  pulmonary  sarcoidosis  was  most  frequently  observed
27/69.2%).
The  most  common  extrapulmonary  manifestations  were
bnormalities  in  calcium  metabolism  --  hypercalciuria
nd/or  hypercalcemia  (6/15.4%),  neurological  (5/12.8%)
nd  skin  (4/10.3%)  involvement.  Skin  involvement  was  not
pparent  at  diagnosis  in  3  patients  and  was  not  typical  in
ne  patient  leading  to  biopsy  for  differential  diagnosis  in  2
f  these  patients.  Biopsies  were  performed  after  diagnosis
nd  dermatologist  evaluation.
Sixteen  patients  performed  previous  nondiagnostic  ﬂex-
ble  bronchoscopy  with  BAL  (16),  bronchial  biopsy  (4),
ransbronchial  lung  biopsy  (2)  or  TBNA  (1).  Additionally  ten
atients  perfomed  BAL  at  the  same  time  as  EBUS-TBNA  and
ne  patient  performed  both  bronchial  and  transbronchial
ung  biopsy  concurrently.  (Table  1)
Concerning  EBUS-TBNA,  an  average  of  2.94  stations  were
unctured,  most  frequently  7,  4R,  11R,  11L  and  4L,  with
n  average  size  of  18.9  ±  6.9  mm  and  an  average  1.7  nee-
le  passes  per  station  (Table  2).  Rapid  on-site  examination
ROSE)  was  performed  in  123  (97.6%)  of  cytological  samples.
With  EBUS-TBNA  it  was  possible  to  obtain  adequate
ytological  samples  in  36  patients  (92.3%),  histological  ade-
uate  samples  in  34  patients  (87.2%)  and  in  38  patients
240  C.  Ribeiro  et  al.
Table  1  Population  characteristics.
Study  population
n (%)
Number  of  patients  39
Gender  (male/female)  17/22  (43.6/56.4)
Age  (mean  ±  SD)  46.7  ±  16
Minimum--maximum  26--79
Radiologic  stage
I 27  (69.2)
II 12  (30.8)
Other  organs  affected  (%)
Calcium  metabolism
(hypercalciuria/hypercalcemia)
6  (15.4)
Neurologic  5  (12.8)
Skin  4  (10.3)
Diagnostic  procedures
Previous
BAL  16  (41.0)
Bronchial  biopsy  4  (10.3)
Transbronchial  lung  biopsy  2  (5.2)
TBNA  1  (2.6)
Concurrent
BAL  10  (25.6)
Bronchial  biopsy  1  (2.6)
Transbronchial  lung  biopsy  1  (2.6)
Subsequent
Skin  biopsy 2  (5.2)
Mediastinoscopy  3  (7.7)
Surgical  lung  biopsy 1  (2.6)
Table  2  Cytological  and  histological  results  and  diagnostic
accuracy  of  EBUS-TBNA.
Average  number  of  stations  punctured  2.94
Average  number  of  needle  passes  by  station  1.7
Adequate  cytological  samples 36  (92.3%)
Conﬁrmation  of  granulomas  in  cytology  29  (80.6%)
ROSE  (%  of  punctured  stations)  123  (97.6%)
Representative  histological  samples  34  (87.2%)
Conﬁrmation  of  granulomas  in  histology  26  (76.5%)
Retrieval  of  representative  material  38  (97.4%)
Conﬁrmation  of  granulomas  in  cytological
and  histological  samples  combined
31  (81.6%)
Conﬁrmation  of  granulomas  in  the  patients  with  a  ﬁnal
diagnosis  of  sarcoidosis  (n  =  33)
Cytology  alone  29  (87.9%)
Histology  alone  26  (78.9%)
Both  cytology  and  histology  31  (93.9%)
True  positives  31
True  negatives  6
False  positives  0
False  negatives  2
Diagnostic  sensitivity  93.9%
Diagnostic  speciﬁcity  100%
Positive  predictive  value  100%
Negative  predictive  value  75.0%
Diagnostic  accuracy  94.8%
Table  3  Nondiagnostic  EBUS-TBNA  results.
Diagnosis  Diagnostic  technique
True
negatives
(6)
Reactive  lymph
node  (3)
Mediastinoscopy  (3)
Tuberculosis  (1) Cultural  examination
of  samples  obtained
by  EBUS-TBNA  (2)
Nontuberculous
mycobacteria  (1)
Non  speciﬁc
infection  (1)
Resolution  after
antibiotic  treatment
(1)
False
negatives
(2)
Sarcoidosis  (2)
Surgical  lung  biopsy
(1)
Bronchial  and
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97.4%)  combining  both.  There  was  evidence  of  epithelioid
oncaseating  granulomas  in  29  (80.6%)  of  patients  in  cyto-
ogical  examination,  26  (76.5%)  in  histological  examination
nd  31  (81.6%)  combining  cytological  and  histological  exam-
nations  (Table  2).
There  were  no  observed  procedural  complications.
Out  of  the  eight  patients  with  suspected  sarcoidosis
hat  did  not  show  presence  of  granulomas  on  EBUS-TBNA,
wo  patients  had  conﬁrmation  of  non-caseating  epitheloid
ell  granulomas  with  other  exams  --  one  patient  presented
n  both  bronchial  and  transbronchial  lung  biopsies  and
ne  patient  underwent  an  open  lung  biopsy  revealing  non-
aseating  epitheloid  cell  granulomas  (Table  3).  Both  of  these
atients  were  stage  II  sarcoidosis.
Out  of  the  remaining  six  patients,  three  patients  under-
ent  mediastinoscopy  (all  with  histology  compatible  with
eactive  lymph  node  in  all  stations)  and  three  patients  did
ot  perform  additional  investigation  as  other  diagnoses  were
onﬁrmed  (tuberculosis,  nontuberculous  mycobacteria)  or
linical  resolution  was  obtained  with  treatment  for  infection
Table  3).  All  the  patients  had  clinical/radiological  suspicion
f  stage  I sarcoidosis.
This  represents  a  calculation  of  true  positives,  true  neg-
tives,  false  positives  and  false  negatives  of  33,  6,  0  and  2
espectively.
Data  analysis  allowed  to  calculate,  for  EBUS-TBNA,  a
ensitivity,  speciﬁcity,  positive  predictive  value,  negative
redictive  value  and  diagnostic  accuracy  of  93.9%,  100%,
00%,  75.0%  and  94.8%,  respectively.
iscussion
BUS-TBNA  is  a  valuable  tool  in  the  diagnostic  algorithm
f  mediastinal  and  hilar  lymphadenopathy.  In  patients  with
linical  and  radiological  features  compatible  with  stages  I
nd  II  sarcoidosis,  EBUS-TBNA  can  conﬁrm  the  diagnosis  by
emonstrating  noncaseating  granulomas  and  exclusion  of
ther  pathologies.  Combining  it  with  other  endoscopic  tech-
iques  can  improve  the  sensitivity  and  speciﬁcity  and  avoid
he  need  for  more  invasive  diagnostic  procedures.A  major  advantage  of  EBUS-TBNA  is  that  it  can  be  done
t  the  same  time  as  other  endoscopic  techniques  such  as
ronchoalveolar  lavage  or  biopsy,  reducing  the  number  of
rocedures  and  anesthetic  complications.
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Rapid  on  site  evaluation  (ROSE)  in  the  vast  majority  of
cytological  samples  enabled  us  to  have  diagnosis  on  site,
reducing  the  number  of  stations  punctured  when  diagno-
sis  was  obtained  or  pursuing  until  adequate  samples  were
retrieved.  In  this  study  we  found  that  adequate  samples
were  obtained  in  38  out  of  39  patients  (97.4%).
Other  studies  have  demonstrated  the  advantages  of
using  EBUS-TBNA  in  patients  with  suspected  sarcoidosis.
Navani  et  al.  described  that  in  patients  with  sarcoidosis,
the  sensitivity  of  EBUS-TBNA  for  detection  of  noncaseating
granulomas  was  85%,  compared  with  a  sensitivity  of  35%  for
standard  bronchoscopic  techniques  [ﬂexible  bronchoscopy
with  transbronchial  lung  biopsy  (TBLB)  without  ﬂuoroscopy
guidance,  broncho-alveolar  lavage  and  bronchial  biopsy  if
endoscopic  ﬁndings]  (P  <  0.001).10
Wong  et  al.  performed  a  study  in  65  patients  and
concluded  that  in  patients  with  a  ﬁnal  diagnosis  of  sarcoido-
sis,  EBUS-TBNA  demonstrated  noncaseating  epithelioid  cell
granulomas  in  56  (91.8%)  of  the  patients  without  reported
complications.7 In  our  study,  of  all  the  patients  that  had
a  deﬁnite  diagnosis  of  sarcoidosis  and  performed  EBUS-
TBNA  (33  patients),  noncaseating  granulomas  were  found  on
31  patients.
Results  from  the  Granuloma  Trial  have  been  published
concluding  that  among  patients  with  suspected  stage  I/II
thoracic  sarcoidosis  undergoing  tissue  conﬁrmation,  the  use
of  endosonographic  nodal  aspiration  compared  with  bron-
choscopic  biopsy  resulted  in  greater  diagnostic  yield.6
Recent  studies  suggest  that  blood  clot  cores  obtained
with  EBUS-TBNA  contain  diagnostic  material  and  should
be  sent  for  histopathological  examination,  as  there  is  the
potential  to  spare  up  to  10%  of  patients  more  invasive  diag-
nostic  biopsy  procedures.11
We  observed  a  high  concordance  between  cytologi-
cal  smear  and  blood  clot  histopathological  analysis  with
24  patients  (72.7%)  demonstrating  granulomas  on  both.  Also
the  histopathological  blood  clot  evaluation  allowed  for  the
diagnosis  in  2  patients  with  no  granuloma  on  the  cytological
specimen  improving  diagnostic  capacity  by  6.5%.  Although
this  was  not  an  end  point  of  our  study,  we  found  that  his-
tological  examination  of  the  blood  clots  cores  raised  the
diagnostic  accuracy  of  the  exam.
Conclusions
Our  study  shows  that  in  selected  patients  with  clinical
and  radiological  features  compatible  with  stages  I and  II
sarcoidosis,  EBUS-TBNA  is  a  valuable  asset  for  obtaining  ade-
quate  tissue  sample  and  conﬁrming  the  diagnosis.
The  high  diagnostic  accuracy  of  EBUS-TBNA  prevents  the
need  for  more  invasive  procedures  such  as  surgical  biopsy.
The  results  obtained  suggest  that,  if  available,  EBUS-TBNA
should  be  considered  as  a  ﬁrst  line  examination  in  the  work
up  of  hilar  and  mediastinal  lymphadenopathy  when  stages  I
or  II  sarcoidosis  is  suspected.
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